Wolverine Trading, LLC Myriad Genetics Inc Put Options Transaction History

Wolverine Trading, LLC

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $533,466 - $652,547	-17,800 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$25.39 - $32.61 $152,340 - $195,660	6,000 Added 50.85%	17,800 $542,000
Q2 2020 Aug 13, 2020	SELL	$10.69 - $16.49 $244,801 - $377,620	-22,900 Reduced 65.99%	11,800 $130,000
Q1 2020 May 11, 2020	BUY	$9.78 - $29.53 $19,560 - $59,060	2,000 Added 6.12%	34,700 $503,000
Q4 2019 Feb 12, 2020	BUY	$20.93 - $35.1 $50,232 - $84,240	2,400 Added 7.92%	32,700 $867,000
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $315,744 - $673,244	-14,300 Reduced 32.06%	30,300 $863,000
Q2 2019 Aug 20, 2019	BUY	$22.67 - $35.0 $1.01 Million - $1.56 Million	44,600 New	44,600 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $283,192 - $473,824	-10,400 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $927,979 - $1.24 Million	-24,700 Reduced 70.37%	10,400 $478,000
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $616,962 - $877,614	21,400 Added 156.2%	35,100 $1.04 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $372,695 - $486,534	-13,100 Reduced 48.88%	13,700 $471,000
Q3 2017 Nov 15, 2017	BUY	$24.01 - $36.2 $643,468 - $970,160	26,800	26,800 $970,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.